Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
117 hedge funds and large institutions have $39.6M invested in Sanofi Contingent Value Rights in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
241% more capital inflows, than outflows
Capital inflows: $4.32M | Capital outflows: $1.27M
7% more funds holding
Funds holding: 109 → 117 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brigade Capital Management
New York
|
+$3.09M |
| 2 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
+$427K |
| 3 |
Bardin Hill Management Partners
New York
|
+$365K |
| 4 |
Highbridge Capital Management
New York
|
+$260K |
| 5 |
SCM
Stonehill Capital Management
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.14M |
| 2 |
Deltec Asset Management
New York
|
-$63.3K |
| 3 |
Basso Capital Management
Stamford,
Connecticut
|
-$25.3K |
| 4 |
TL
TowerView LLC
New York
|
-$12.7K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$10.2K |
GCVRZ Hedge Fund Activity: Q3 2016 in Review
117 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2016, worth a combined $39.6M — up 15% from $34.4M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GCVRZ positions and 4 closed out — a net gain of 10 holders — while 16 added to existing stakes and 16 trimmed.
The largest buyer was Brigade Capital Management, opening a new position worth an estimated $3.09M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $1.14M sold.
- 117 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2016, up from 109 in Q2 2016.
- Funds reported $39.6M of Sanofi Contingent Value Rights stock for Q3 2016, up 15% quarter-over-quarter.
- 14 funds opened new Sanofi Contingent Value Rights positions in Q3 2016 and 4 closed out, a net change of +10 holders.
- The largest Sanofi Contingent Value Rights buyer in Q3 2016 was Brigade Capital Management, an estimated $3.09M added.
- The largest Sanofi Contingent Value Rights seller in Q3 2016 was Oxford Asset Management, an estimated $1.14M sold.
Based on aggregated 13F filings for Q3 2016.